Durability of effects from short-term economic incentives for clinic attendance among HIV positive adults in Tanzania: long-term follow-up of a randomised controlled trial

Carolyn A Fahey, Prosper F Njau, Nicole K Kelly, Rashid S Mfaume, Patrick T Bradshaw, William H Dow, Sandra I McCoy, Carolyn A Fahey, Prosper F Njau, Nicole K Kelly, Rashid S Mfaume, Patrick T Bradshaw, William H Dow, Sandra I McCoy

Abstract

Introduction: Conditional economic incentives are shown to promote medication adherence across a range of health conditions and settings; however, any long-term harms or benefits from these time-limited interventions remain largely unevaluated. We assessed 2-3 years outcomes from a 6-month incentive programme in Tanzania that originally improved short-term retention in HIV care and medication possession.

Methods: We traced former participants in a 2013-2016 trial, which randomised 800 food-insecure adults starting HIV treatment at three clinics to receive either usual care (control) or up to 6 months of cash or food transfers (~US$11/month) contingent on timely attendance at monthly clinic appointments. The primary intention-to-treat analysis estimated 24-month and 36-month marginal risk differences (RD) between incentive and control groups for retention in care and all-cause mortality, using multiple imputation for a minority of missing outcomes. We also estimated mortality HRs from time-stratified Cox regression.

Results: From 3 March 2018 to 19 September 2019, we determined 36-month retention and mortality statuses for 737 (92%) and 700 (88%) participants, respectively. Overall, approximately 660 (83%) participants were in care at 36 months while 43 (5%) had died. There were no differences between groups in retention at 24 months (86.5% intervention vs 84.4% control, RD 2.1, 95% CI -5.2 to 9.3) or 36 months (83.3% vs 77.8%, RD 5.6, -2.7 to 13.8), nor in mortality at either time point. The intervention group had a lower rate of death during the first 18 months (HR 0.27, 95% CI 0.10 to 0.74); mortality was similar thereafter (HR 1.13, 95% CI 0.33 to 3.79).

Conclusion: These findings confirm that incentives are a safe and effective tool to promote short-term adherence and potentially avert early deaths at the critical time of HIV treatment initiation. Complementary strategies are recommended to sustain lifelong retention in HIV care.

Trial registration number: NCT01957917.

Keywords: HIV; epidemiology; health services research; randomised control trial; treatment.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Trial profile, adult HIV treatment initiates in Tanzania, 2013–2018. ART, antiretroviral therapy. *Four screened patients were excluded for unknown reasons (missing screening data).
Figure 2
Figure 2
Kaplan-Meier survival plot of time to all-cause mortality among adult HIV treatment initiates in Tanzania, 2013–2018.

References

    1. Dow WH, White JS, Bertozzi S. Incentivizing health care utilization and health outcomes. In: Scheffler R, ed. Handbook of global health economics and public policy. World Scientific, 2016: 421–51.
    1. Gertler P. Do conditional cash transfers improve child health? Evidence from PROGRESA’s control randomized experiment. Am Econ Rev 2004;94:336–41. 10.1257/0002828041302109
    1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487–97. 10.1056/NEJMra050100
    1. Petry NM, Rash CJ, Byrne S, et al. . Financial reinforcers for improving medication adherence: findings from a meta-analysis. Am J Med 2012;125:888–96. 10.1016/j.amjmed.2012.01.003
    1. DeFulio A, Silverman K. The use of incentives to reinforce medication adherence. Prev Med 2012;55(Suppl):S86–94. 10.1016/j.ypmed.2012.04.017
    1. Cohen MS, Smith MK, Muessig KE, et al. . Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? The Lancet 2013;382:1515–24. 10.1016/S0140-6736(13)61998-4
    1. Heestermans T, Browne JL, Aitken SC, et al. . Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa: a systematic review. BMJ Glob Health 2016;1:e000125. 10.1136/bmjgh-2016-000125
    1. UNAIDS . Social protection: a fast-track commitment to end AIDS — guidance for policy-makers, and people living with, at risk of or affected by HIV. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS), 2018.
    1. McCoy SI, Njau PF, Fahey C, et al. . Cash vs. food assistance to improve adherence to antiretroviral therapy among HIV-infected adults in Tanzania. AIDS 2017;31:815–25. 10.1097/QAD.0000000000001406
    1. Fahey CA, Njau PF, Katabaro E, et al. . Financial incentives to promote retention in care and viral suppression in adults with HIV initiating antiretroviral therapy in Tanzania: a three-arm randomised controlled trial. Lancet HIV 2020;7:e762–71. 10.1016/S2352-3018(20)30230-7
    1. Galárraga O, Sosa-Rubí SG. Conditional economic incentives to improve HIV prevention and treatment in low-income and middle-income countries. Lancet HIV 2019;6:e705–14. 10.1016/S2352-3018(19)30233-4
    1. de Walque D. The use of financial incentives to prevent unhealthy behaviors: a review. Soc Sci Med 2020;261:113236. 10.1016/j.socscimed.2020.113236
    1. Baird S, McIntosh C, Özler B. When the money runs out: do cash transfers have sustained effects on human capital accumulation? J Dev Econ 2019;140:169–85. 10.1016/j.jdeveco.2019.04.004
    1. McCoy SI, Njau PF, Czaicki NL, et al. . Rationale and design of a randomized study of short-term food and cash assistance to improve adherence to antiretroviral therapy among food insecure HIV-infected adults in Tanzania. BMC Infect Dis 2015;15:490. 10.1186/s12879-015-1186-3
    1. Juszczak E, Altman DG, Hopewell S, et al. . Reporting of multi-arm parallel-group randomized trials: extension of the CONSORT 2010 statement. JAMA 2019;321:1610–20. 10.1001/jama.2019.3087
    1. Ballard T, Coates J, Swindale A. Household hunger scale: indicator definition and measurement guide. 360. Washington, DC: Food and Nutrition Technical Assistance II Project, FHI, 2011.
    1. NACP . National guidelines for the management of HIV and AIDS. United Republic of Tanzania Ministry of Health, Community Development, Gender, Elderly, and Children, National AIDS Control Programme (NACP), 2017.
    1. Yotebieng M, Thirumurthy H, Moracco KE, et al. . Conditional cash transfers to increase retention in PMTCT care, antiretroviral adherence, and postpartum virological suppression: a randomized controlled trial. J Acquir Immune Defic Syndr 2016;72(Suppl 2):S124–9. 10.1097/QAI.0000000000001062
    1. PEPFAR . Monitoring, evaluation, and reporting indicator reference guide: MER 2.0 (version 2.3). Washington, DC: PEPFAR, 2018.
    1. Williams R. Using the margins command to estimate and interpret adjusted predictions and marginal effects. Stata J 2012;12:308–31. 10.1177/1536867X1201200209
    1. Klein D. MIMRGNS: Stata module to run margins after mi estimate. Boston College Department of Economics, 2014.
    1. Kadota JL, Fahey CA, Njau PF, et al. . The heterogeneous effect of short-term transfers for improving ART adherence among HIV-infected Tanzanian adults. AIDS Care 2018;30:18–26. 10.1080/09540121.2018.1476666
    1. Rubin DR. Multiple imputation for nonresponse in surveys. New York: John Wiley & Sons, Inc, 1987.
    1. Royston P, White I. Multiple Imputation by Chained Equations (MICE): Implementation in Stata. J Stat Softw 2011;45:1–20. 10.18637/jss.v045.i04
    1. Packel L, Fahey C, Njau P, et al. . Implementation science using Proctor's framework and an adaptation of the multiphase optimization strategy: optimizing a financial incentive intervention for HIV treatment adherence in Tanzania. J Acquir Immune Defic Syndr 2019;82(Suppl 3):S332–8. 10.1097/QAI.0000000000002196
    1. Packel L, Njau P, Fahey C, et al. . Optimizing the efficiency and implementation of cash transfers to improve adherence to antiretroviral therapy: study protocol for a cluster randomized controlled trial. Trials 2020;21:963. 10.1186/s13063-020-04899-7
    1. Deci EL, Koestner R, Ryan RM. A meta-analytic review of experiments examining the effects of extrinsic rewards on intrinsic motivation. Psychol Bull 1999;125:627–68. 10.1037/0033-2909.125.6.627
    1. Woller G. Livelihood and food security conceptual framework. 360. Washington, DC: Livelihood and Food Security Technical Assistance (LIFT), FHI, 2011.
    1. Whetten K, Reif S, Whetten R, et al. . Trauma, mental health, distrust, and stigma among HIV-positive persons: implications for effective care. Psychosom Med 2008;70:531–8. 10.1097/PSY.0b013e31817749dc
    1. Fox MP, Rosen S. Retention of adult patients on antiretroviral therapy in low- and middle-income countries: systematic review and meta-analysis 2008-2013. J Acquir Immune Defic Syndr 2015;69:98–108. 10.1097/QAI.0000000000000553
    1. Roelen K, Devereux S, Abdulai A. How to make ‘cash plus’ work: linking cash transfers to services and sectors. Florence: UNICEF Office of Research-Innocenti, 2017.
    1. Claborn KR, Meier E, Miller MB, et al. . A systematic review of treatment fatigue among HIV-infected patients prescribed antiretroviral therapy. Psychol Health Med 2015;20:255–65. 10.1080/13548506.2014.945601

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다